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Abstract
Normative models are a class of emerging statistical techniques useful for understanding the heterogeneous biology
underlying psychiatric disorders at the level of the individual participant. Analogous to normative growth charts used in
paediatric medicine for plotting child development in terms of height or weight as a function of age, normative models chart
variation in clinical cohorts in terms of mappings between quantitative biological measures and clinically relevant variables.
An emerging body of literature has demonstrated that such techniques are excellent tools for parsing the heterogeneity in
clinical cohorts by providing statistical inferences at the level of the individual participant with respect to the normative
range. Here, we provide a unifying review of the theory and application of normative modelling for understanding the
biological and clinical heterogeneity underlying mental disorders. We first provide a statistically grounded yet non-technical
overview of the conceptual underpinnings of normative modelling and propose a conceptual framework to link the many
different methodological approaches that have been proposed for this purpose. We survey the literature employing these
techniques, focusing principally on applications of normative modelling to quantitative neuroimaging-based biomarkers in
psychiatry and, finally, we provide methodological considerations and recommendations to guide future applications of these
techniques. We show that normative modelling provides a means by which the importance of modelling individual
differences can be brought from theory to concrete data analysis procedures for understanding heterogeneous mental
disorders and ultimately a promising route towards precision medicine in psychiatry.
In most areas of medicine, biomarkers that objectively
indicate disease state have revolutionized diagnosis and
treatment allocation. In contrast, psychiatric disorders are
still diagnosed exclusively on the basis of symptoms and
biological tests to assist diagnosis or treatment allocation
remain to be developed [1]. This yields clinical groups that
are highly heterogenous, both in terms of clinical pre-
sentation and underlying biology, which is a major barrier
to understanding underlying mechanisms and developing
better treatments [1–3]. This is widely recognized at a
theoretical level and over the years, many different theo-
retical models have been proposed to explain the hetero-
geneity of psychiatric disorders [4–9]. These emphasize the
myriad pathological mechanisms that may converge on
the same symptoms in different participants [4, 5] and that
the same underlying biological risk factors may result in a
different clinical phenotype in different individuals
depending on the context, genetic background and critical
time window [4, 9]. Heterogeneity remains the dominant
theme even in recent large-scale theoretical initiatives such
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as the Research Domain Criteria (RDoC) [6, 7] and the
European Roadmap for Mental Health Research (ROA-
MER) [8]. All these theoretical models are founded on an
implicit recognition of the importance of modelling indi-
vidual differences within and across clinical cohorts
[10, 11]. It is very important to recognize, however, that this
broad theoretical recognition is not reflected in the data
analysis strategies employed in practice. Instead, the over-
whelming majority of analysis approaches remain focussed
on group averages (e.g. the ‘average patient’) and regard
individual differences principally as noise.1
Normative modelling is an emerging approach that can
address this challenge by providing statistical inferences at
the level of the individual with respect to an expected pat-
tern [12]. This is analogous to the widespread use of nor-
mative growth charts in paediatric medicine to map child
height or weight as a function of age with respect to centiles
of variation in a reference population [13]. Normative
modelling generalizes this notion by substituting these
variables for clinically relevant variables then applying
automated statistical techniques to map centiles of variation
across the cohort. This is increasingly used to map variation
between cognitive, clinical or demographic variables and
quantitative biomarkers derived from neuroimaging
[12, 14–17]. The key feature of normative modelling that
makes it useful for stratifying cohorts is that it permits the
detection and mapping of distinct patterns of abnormality in
individuals without requiring a consistent neurobiological
signature across all individuals.
Whilst early applications focused on brain development
and ageing [16, 18], normative modelling has recently been
shown to be highly promising for psychiatry [12, 14, 17, 19–
21]. First, to map variation related to brain development and
ageing in psychiatric disorders, which is appealing given the
neurodevelopmental basis of mental disorders [22]. For
example, neurodevelopmental normative models have been
used in the context of schizophrenia [17, 19], attention
deficit/hyperactivity disorder (ADHD) [20, 23] and autism
[21, 24] to help understand the emergence of mental dis-
orders as deviations from an expected developmental tra-
jectory and identify individuals following an atypical
trajectory. Second, normative modelling can also be
abstracted beyond development to chart the spectrum of
functioning across any cognitive domain. It has been used,
for example, to chart variation in reward systems via map-
pings between trait measures of reward sensitivity and
reward-related brain activity [12]. Finally, normative models
can help to understand healthy variation and move beyond
simple dimensional theories of mental disorders [25].
Here, we provide a unifying review of normative mod-
elling for charting individual variation across different
behavioural, demographic and biological dimensions,
thereby helping to understand heterogeneity within clinical
cohorts. We first provide a statistically grounded, yet non-
technical overview of its conceptual underpinnings and
propose a framework to link the many different methodo-
logical approaches that have been proposed. Second, we
outline connections between normative modelling and
existing approaches for tackling heterogeneity including
clustering [26] and ‘brain age’ approaches that characterize
subjects in terms of a difference between a brain-derived
predicted age and true chronological age [27, 28]. Third, we
survey the literature employing normative modelling in
clinical conditions. Fourth, we discuss normative modelling
as a tool for finding structure in large cohorts, which is
important given the recent shifts towards ‘big data’ neu-
roscience and large population-based cohorts [29–31].
Finally, we provide recommendations for future studies and
critically evaluate the limitations of normative modelling.
Introduction to normative modelling for
understanding heterogeneity in clinical
cohorts
Normative modelling is a statistical framework for mapping
between behavioural, demographic or clinical character-
istics and a quantitative biological measure, providing
estimates of centiles of variation across the population
(Fig. 1a). Normative modelling provides a concrete method
for studying individual differences and parsing hetero-
geneity across cohorts because it provides statistical infer-
ences at the level of the individual participant as to the
degree to which each individual deviates from the norma-
tive pattern and allows these deviations to be mapped in
each individual. In other words, normative modelling pro-
vides a way to quantify and characterize the manner in
which different individuals deviate from the expected pat-
tern, and from one another. Importantly, this does not
require that atypicalities overlap across participants (e.g. in
the same brain regions) or even that a consistent pattern of
deviation exists. Therefore, this accommodates the con-
vergence of multiple pathological pathways on the same
symptoms in different individuals [4]. This is clearly dif-
ferent from case-control analyses, which all focus on first
order statistics (group means), thereby seeking a consistent
pattern of atypicality (i.e. the ‘average patient’). In a case-
control context, heterogeneity becomes apparent via infla-
tion of the model residuals and ultimately decreases
1 This includes classical analysis methods based on the general linear
model (e.g. t-tests and analysis of (co-) variance) plus classical and
supervised machine learning classification models (e.g. linear dis-
criminant analysis, logistic regression and support vector machines)
and unsupervised clustering methods (e.g. k-means), where—at best—
confound regressors are used to remove some of the cross-subject
variation.
1416 A. F. Marquand et al.
sensitivity for detecting disorder-related effects. In contrast,
normative modelling explicitly models heterogeneity
because it focuses on modelling individual variation around
the mean using second order statistics (variances). There-
fore, normative modelling explicitly characterizes and
quantifies the heterogeneity underlying clinical conditions
at a finer grained level than is afforded by group averages.
Normative modelling also does not require that the clinical
group can be cleanly partitioned into subtypes [26] although
it can be used to generate features for clustering. Normative
modelling can be used to estimate many different kinds of
mappings based on the variables chosen, but here we focus
on mappings between behavioural or demographic
measures and a quantitative biological readout, most com-
monly derived from neuroimaging.
Procedurally, normative modelling involves four steps
(Fig. 1b): First, a reference cohort and a set of variables are
chosen to define the mapping and population over which
variation is measured. Second, a statistical model is esti-
mated to model variance in a response variable (a.k.a. target
or dependent variable) from a set of clinically relevant
covariates (predictor or independent variables) across the
reference cohort. For example, one may estimate a norma-
tive model for cortical thickness as a function of age and
gender using a population-based reference cohort. Third, it is
necessary to assess the accuracy of the normative model for
Fig. 1 Conceptual overview of normative modelling. a Normative
modelling is similar to the use of growth charts in paediatric medicine,
except the conventional response variable (e.g. height or weight) is
substituted for a quantitative biological readout (e.g. regional brain
activity). The classical covariates (age and sex) can also be substituted
for clinically relevant variables. Normative modelling provides sta-
tistical inference at the level of each subject with respect to the nor-
mative model (red figure). b Procedural overview of normative
modelling. After the choice of reference cohort and variables, the
normative model is estimated, before being validated out of sample on
new response variables and covariates (y* and x*, respectively).
Finally, the estimated model can be applied to a target cohort (e.g.
clinical cohort). c A common configuration for normative modelling of
neuroimaging data, where a separate normative model is estimated for
each sampled brain location. This can be described by a set of func-
tions (y = f(x)) predicting neurobiological response variables (y) from
clinical covariates (x). d Normative models can also be estimated for
the opposite mapping, where brain measures are chosen as covariates
and age or other covariates are chosen as a response variable. See text
for further details
Conceptualizing mental disorders as deviations from normative functioning 1417
predicting the response variable (e.g. mean-squared error,
explained variance). To ensure accurate estimates of gen-
eralizability, this must be performed on withheld data (e.g.
under cross-validation). Finally, this model can be applied to
quantifying the deviations of samples from a target cohort
(e.g. clinical cohort) with respect to this reference model.
Many regression models have been proposed for nor-
mative modelling, including hierarchical linear models,
polynomial regression, quantile regression, support vector
regression and Gaussian process regression (Table 1). The
estimation of normative models is conceptually similar to
classical growth charts, for which many approaches have
been proposed [13]. In both cases, the data make multiple
demands from the regression model including ensuring
precise estimation of outer centiles (where data are spar-
sest), ensuring centiles vary smoothly as a function of the
covariates (and do not cross) and the ability to estimate
deviations for individual samples via analytical formulae
(e.g. Z-scores) [32]. In order to provide a conceptual fra-
mework linking these approaches, we categorize different
approaches according to three criteria: (i) the choice of
covariates and response variables; (ii) the degree to which
the model separates different sources of variation and (iii)
the degree to which the model permits statistical inference
the individual level. However, other features are also
important, for instance ability to model non-linear
relationships.
Choice of covariates and response variables
A simple way to categorize different approaches is in terms
of the variables that define the mapping. One common
configuration (Fig. 1c) uses age as a covariate, often in
combination with other clinical or demographic variables to
predict a quantitative biological readout. However, there are
other possibilities: for example, the mapping can be inver-
ted such that age is the response variable which is predicted
from clincal or demographic variables (Fig. 1d). This is the
approach used by ‘brain age’ models [27, 28] which use
multivariate regression to predict age from a pattern of
brain-derived measures. For linear models, it is obvious that
an association can be detected in either direction simply by
inverting the linear model. However, the interpretation of
the centiles of variation and regression coefficients differs
and we consider that charting variation over the biological
readout is more appealing because it directly mirrors the use
of growth-charting in paediatric medicine.
As noted, normative models are also not restricted to
charting variation across development. By substituting age
for other variables, normative models can chart variation in
any kind of mapping, for example to link cognitive scores
with brain activity patterns [12].
Separating different sources of variation
across the cohort
Normative modelling principally aims to model variation
across the cohort over and above estimation of mean
effects. To achieve this effectively, it is important to
separate different sources of variation, most importantly
to differentiate actual variation within the data (i.e. across
participants) from variability due to parameter and model
uncertainty (i.e. induced variability due to a lack of data).
In normative modelling, we quantify these variabilities
using two types of uncertainty commonly defined in
machine learning [33]: (i) irreducible (or ‘aleatoric’)
uncertainty that reflects true underlying variability that
cannot be reduced with more data; (ii) reducible (or
‘epistemic’) variation that reflects parameter uncertainty
or ignorance about the true model and can be reduced by
more data. Aleatoric uncertainty is of primary interest for
stratification because it reflects variation across subjects
whereas epistemic uncertainty is nuisance variation that it
is desirable to minimize. The degree to which different
approaches account for these sources of variability can be
classified hierarchically (Fig. 2): the simplest approach
involves estimating the mean effect only and assessing
deviations from the expected pattern using the model
residuals (Fig. 2a, b) [19, 27]. Whilst this is appealing in
its simplicity, it provides no estimate of variation across
the cohort and cannot provide statistical inferences at the
individual level (see below). This has been addressed in
different ways, for example via estimating confidence
intervals via a post hoc regression between the residuals
of the model against the true response variable [14] or
using quantile regression to directly estimate centiles of
variation in the data [34]. These approaches provide sta-
tistical estimates of variation within the population and
can indicate if a particular participant deviates from the
expected pattern at a given confidence level, but they do
not fully account for different sources of uncertainty, e.g.
uncertainty in the estimation of the centiles (Fig. 2c).
Bayesian methods such as Gaussian process regression
[12, 16, 35] provide one solution to this problem (Fig. 2d)
by estimating distinct variance components and providing
predictions for each participant that account for all sour-
ces of uncertainty. This is important for two reasons: first,
it provides estimates of centiles of variation within the
reference cohort that are not influenced by data density;
second, it allows all sources of uncertainty to be taken into
account when making predictions. This provides the
desirable property that inferences become more con-
servative in regions of the input space where data are
sparse. With these complementary purposes in mind, it
may be desirable to report different variance components
separately.
1418 A. F. Marquand et al.
Ta
bl
e
1
S
tu
di
es
ut
ili
zi
ng
no
rm
at
iv
e
m
od
el
lin
g
te
ch
ni
qu
es
in
cl
in
ic
al
co
nd
iti
on
s
C
lin
ic
al
ph
en
ot
yp
e
N
or
m
at
iv
e
re
sp
on
se
va
ri
ab
le
C
ov
ar
ia
te
s
R
ef
er
en
ce
co
ho
rt
T
ar
ge
t
co
ho
rt
A
lg
or
ith
m
S
ep
ar
at
e
va
ri
an
ce
co
m
po
ne
nt
s
S
in
gl
e
su
bj
ec
t
pr
ed
ic
tio
n
R
ef
.
A
D
H
D
di
ag
no
si
s
F
un
ct
io
na
l
co
nn
ec
tiv
ity
m
ea
su
re
s
de
ri
ve
d
fr
om
re
st
in
g
fM
R
I
A
ge
P
op
ul
at
io
n-
ba
se
d
co
ho
rt
P
ar
tic
ip
an
ts
w
ith
A
D
H
D
P
ol
yn
om
ia
l
re
gr
es
si
on
N
o
N
um
er
ic
al
[2
0]
A
D
H
D
di
ag
no
si
s
B
ra
in
vo
lu
m
e
A
ge
an
d
ge
nd
er
H
ea
lth
y
re
fe
re
nc
e
co
ho
rt
A
du
lts
w
ith
A
D
H
D
G
au
ss
ia
n
pr
oc
es
s
re
gr
es
si
on
Y
es
S
ta
tis
tic
al
[2
3]
A
D
H
D
sy
m
pt
om
s
R
ew
ar
d-
re
la
te
d
br
ai
n
ac
tiv
ity
de
ri
ve
d
fr
om
ta
sk
fM
R
I
D
el
ay
di
sc
ou
nt
in
g
H
ea
lth
y
vo
lu
nt
ee
rs
H
ea
lth
y
vo
lu
nt
ee
rs
G
au
ss
ia
n
pr
oc
es
s
re
gr
es
si
on
an
d
ex
tr
em
e
va
lu
e
st
at
is
tic
s
Y
es
S
ta
tis
tic
al
[1
2]
A
ut
is
m
C
or
tic
al
T
hi
ck
ne
ss
A
ge
an
d
ge
nd
er
T
yp
ic
al
ly
de
ve
lo
pi
ng
co
ho
rt
P
ar
tic
ip
an
ts
w
ith
au
tis
m
G
au
ss
ia
n
pr
oc
es
s
re
gr
es
si
on
an
d
ex
tr
em
e
va
lu
e
st
at
is
tic
s
Y
es
S
ta
tis
tic
al
[2
4]
A
ut
is
m
C
or
tic
al
th
ic
kn
es
s
A
ge
T
yp
ic
al
ly
de
ve
lo
pi
ng
co
ho
rt
P
ar
tic
ip
an
ts
w
ith
au
tis
m
L
oc
al
po
ly
no
m
ia
l
re
gr
es
si
on
N
o
S
ta
tis
tic
al
[2
1]
A
ut
is
m
A
lp
ha
ba
nd
br
ai
n
ac
tiv
ity
de
ri
ve
d
fr
om
el
ec
tr
o-
en
ce
ph
al
og
ap
hy
A
ge
T
yp
ic
al
ly
de
ve
lo
pi
ng
co
ho
rt
P
ar
tic
ip
an
ts
w
ith
au
tis
m
L
oc
al
po
ly
no
m
ia
l
re
gr
es
si
on
N
o
N
um
er
ic
al
[4
4]
B
ip
ol
ar
di
so
rd
er
B
ra
in
vo
lu
m
e
A
ge
an
d
ge
nd
er
H
ea
lth
y
re
fe
re
nc
e
co
ho
rt
A
du
lts
w
ith
B
ip
ol
ar
di
so
rd
er
G
au
ss
ia
n
pr
oc
es
s
re
gr
es
si
on
Y
es
S
ta
tis
tic
al
[1
7]
C
og
ni
tio
n:
pr
oc
es
si
ng
sp
ee
d
A
ge
B
ra
in
vo
lu
m
e
H
ea
lth
y
vo
lu
nt
ee
rs
H
ea
lth
y
vo
lu
nt
ee
rs
S
up
po
rt
ve
ct
or
re
gr
es
si
on
N
o
S
ta
tis
tic
al
[1
4]
C
og
ni
tio
n:
In
hi
bi
to
ry
C
on
tr
ol
T
as
k-
re
la
te
d
fM
R
I
da
ta
A
ge
H
ea
lth
y
vo
lu
nt
ee
rs
H
ea
lth
y
vo
lu
nt
ee
rs
H
ie
ra
rc
hi
ca
l
lin
ea
r
m
od
el
lin
g
N
o
N
um
er
ic
al
[4
5]
S
us
ta
in
ed
at
te
nt
io
n
F
un
ct
io
na
l
co
nn
ec
tiv
ity
m
ea
su
re
s
de
ri
ve
d
fr
om
re
st
in
g
fM
R
I
A
ge
P
op
ul
at
io
n-
ba
se
d
co
ho
rt
P
ar
tic
ip
an
ts
w
ith
A
D
H
D
P
ol
yn
om
ia
l
re
gr
es
si
on
N
o
S
ta
tis
tic
al
[2
0]
M
ild
co
gn
iti
ve
im
pa
ir
m
en
t
an
d
de
m
en
tia
B
ra
in
vo
lu
m
e
A
ge
P
op
ul
at
io
n-
ba
se
d
co
ho
rt
P
ar
tic
ip
an
ts
w
ith
m
ild
co
gn
iti
ve
im
pa
ir
m
en
t
an
d
A
lz
he
im
er
’s
di
se
as
e
P
ar
tia
l
le
as
t
sq
ua
re
s
an
d
qu
an
til
e
re
gr
es
si
on
N
o
S
ta
tis
tic
al
[3
4]
M
ild
co
gn
iti
ve
im
pa
ir
m
en
t
an
d
de
m
en
tia
B
ra
in
vo
lu
m
e
A
ge
,
se
x,
to
ta
l
gr
ey
-
an
d
w
hi
te
m
at
te
r
vo
lu
m
e,
to
ta
l
ce
re
br
os
pi
na
l
fl
ui
d,
M
R
I
fi
el
d
st
re
ng
th
M
ul
ti-
st
ud
y
he
al
th
y
re
fe
re
nc
e
co
ho
rt
H
ea
lth
y
pa
rt
ic
ip
an
ts
,
pa
rt
ic
ip
an
ts
w
ith
m
ild
co
gn
iti
ve
im
pa
ir
m
en
t
an
d
de
m
en
tia
G
au
ss
ia
n
pr
oc
es
s
re
gr
es
si
on
Y
es
S
ta
tis
tic
al
[1
6]
P
sy
ch
os
is
sy
m
pt
om
s
A
ge
C
og
ni
tiv
e
sc
or
es
m
ea
su
ri
ng
ex
ec
ut
iv
e
fu
nc
tio
n,
m
em
or
y,
co
m
pl
ex
co
gn
iti
on
,
so
ci
al
co
gn
iti
on
an
d
se
ns
or
im
ot
or
pr
oc
es
si
ng
D
ev
el
op
m
en
ta
l
st
ud
y
co
ho
rt
co
nt
ai
ni
ng
ty
pi
ca
lly
de
ve
lo
pi
ng
ad
ol
es
ce
nt
s
an
d
ad
ol
es
ce
nt
s
w
ith
ps
yc
ho
si
s
sp
ec
tr
um
sy
m
pt
om
s
(2
le
ve
ls
)
an
d
ot
he
r
ps
yc
ho
pa
th
ol
og
ie
s
D
ev
el
op
m
en
ta
l
st
ud
y
co
ho
rt
co
nt
ai
ni
ng
ty
pi
ca
lly
de
ve
lo
pi
ng
ad
ol
es
ce
nt
s
an
d
ad
ol
es
ce
nt
s
w
ith
ps
yc
ho
si
s
sp
ec
tr
um
sy
m
pt
om
s
(2
le
ve
ls
)
an
d
ot
he
r
ps
yc
ho
pa
th
ol
og
ie
s
L
in
ea
r
re
gr
es
si
on
N
o
N
um
er
ic
al
[1
9]
S
ch
iz
op
hr
en
ia
B
ra
in
vo
lu
m
e
A
ge
an
d
ge
nd
er
H
ea
lth
y
re
fe
re
nc
e
co
ho
rt
A
du
lts
w
ith
S
ch
iz
op
hr
en
ia
G
au
ss
ia
n
pr
oc
es
s
re
gr
es
si
on
Y
es
S
ta
tis
tic
al
[1
7]
S
ch
iz
op
hr
en
ia
L
on
gi
tu
di
na
l
co
rt
ic
al
th
ic
kn
es
s
m
ea
su
re
s
de
ri
ve
d
fr
om
st
ru
ct
ur
al
M
R
I
A
ge
H
ea
lth
y
re
fe
re
nc
e
co
ho
rt
C
hi
ld
re
n,
ad
ol
es
ce
nt
s
an
d
ad
ul
ts
w
ith
ch
ild
ho
od
on
se
t
sc
hi
zo
ph
re
ni
a
P
en
al
iz
ed
sp
lin
e
m
od
el
s
N
o
N
um
er
ic
al
[4
6]
D
if
fe
re
nt
m
et
ho
ds
ar
e
cl
as
si
fi
ed
in
te
rm
s
of
th
e
ch
oi
ce
of
co
va
ri
at
es
an
d
re
sp
on
se
va
ri
ab
le
s,
w
he
th
er
th
ey
es
tim
at
e
se
pa
ra
te
va
ri
an
ce
co
m
po
ne
nt
s
an
d
in
te
rm
s
of
th
e
de
gr
ee
of
si
ng
le
-s
ub
je
ct
pr
ed
ic
tio
n
th
at
th
ey
pr
ov
id
e
(s
ee
te
xt
fo
r
de
ta
ils
)
Conceptualizing mental disorders as deviations from normative functioning 1419
Degree of individual prediction
The ability of the model to perform single participant infer-
ence can be classified hierarchically. At the simplest level
(‘numerical inference’; Fig. 2a, b), the model only provides
numerical deviations (i.e. residuals of the target cohort from
the reference model). This is the approach taken by most brain
age approaches [27] and permits group-level inferences about
how deviations correlate—for example—with symptoms. In
contrast, some models provide estimates of centiles of varia-
tion within the population (‘statistical inference’; e.g. quantile
regression [34] and Bayesian techniques [12, 16]). This pro-
vides inferences as to whether each individual deviates from
the model at a given statistical significance level (Fig. 2c).
Some studies have derived variance estimates via post hoc
regression on the model residuals [14] and atypicality cutoffs
could also be defined post hoc, although this must be done on
unseen data to remain unbiased. However, as described
above, it is important to recognize whether predictions
account for all sources of variance. If they do not, they may
yield overly optimistic inferences. This can be addressed
using models that estimate separate variance components for
different types of variance and account for all uncertainty in
the predictions (Fig. 2d).
In addition to mapping deviations in individuals, it is
often desirable to estimate participant-level summary sta-
tistics for the overall deviation from the normative pattern.
Different methods have been proposed for this, e.g.: com-
bining deviations across all voxels [16] or modelling the
most extreme deviations in each subject using extreme
value statistics [12].
Relationships to other approaches for
parsing heterogeneity
Normative modelling is complementary to the predominant
approach for tackling heterogeneity in mental disorders, i.e.
Fig. 2 Separating different sources of uncertainty in normative mod-
elling. Panels a and b show the simplest approach for normative models
which do not quantify uncertainty at all (a: linear model, b: non-linear
model). Instead, deviations from the model (red figures) are assessed
via the residuals from a regression function (blue lines). In red, the
corresponding equation for assessing deviations from the model is
shown where deviation from the normative model are assessed simply
as the difference between the true (y) and predicted (by) normative
response variable for each subject. c Some models estimate centiles of
variation explicitly either via separate model fits or post hoc to the
initial regression fit (blue dotted lines). This captures ‘aleatoric’ or
irreducible variation in the cohort which shows how subjects vary
across the population (σ2a). However, there is also uncertainty
associated with each of these centiles of variation (shaded blue
regions), which is highest in regions of low data density and should be
accounted for. d Some models separate and take all sources of variation
into account (i.e. also including ‘epistemic’ uncertainty (σ2e ), which can
be reduced by the addition of more data). This allows the model to
automatically adjust predictions, becoming more conservative in
regions where data are sparse. This is shown by a widening of the
statistical intervals, although note that these intervals now have a dif-
ferent interpretation to those in (c). For example, the right-most figure
in (d) would not be judged as an outlier, whereas the same figure may
be judged as an outlier in models that do not account for all sources of
uncertainty (c). This is important to prevent a subject being declared as
‘atypical’ simply because of data sparsity. See text for further details
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subtyping using clustering algorithms. Clustering has been
widely applied [26] and is often useful. However, it also
suffers from limitations: first, clustering assumes that the
clinical group can be cleanly partitioned into subtypes.
However, this assumption is seldom evaluated, which is
problematic because clustering algorithms always yield a
result, regardless of whether clusters are ‘really there’
[26, 36]. Second, clustering focuses on group averages and
does not fully model individual variation within clusters. In
other words, most clustering algorithms regard piece-wise
constant clusters as atomic units. Whilst some algorithms
provide ‘soft’ cluster assignments that capture some varia-
tion within clusters, this cannot accurately model, for
example, a spectrum of functioning. In contrast, normative
modelling shifts the analytical focus: (i) away from group
means to understanding cohort variation (i.e. from first- to
second-order statistics); (ii) towards understanding variation
across individuals and (iii) towards mapping deviations at
the level of individual.
Normative modelling is complementary to alternative
techniques for individual prediction; for example, super-
vised discriminative models [3] can assess the degree of
group separation in a case-control sense and therefore
provide predictions that are specific for certain disorders.
On the other hand, normative modelling can be used to
understand the variation across the cohort independently of
the clinical labels.
Brain age models are related and complementary to
normative modelling. They can be considered as a type of
normative model which estimate the opposite mapping (i.e.
brain readouts as covariates and age as the response vari-
able; Fig. 1d). As noted, choosing age as a covariate mirrors
growth-charting in paediatric medicine and allows the
regional deviations in each subject to be mapped, which is
desirable for interpretation. In contrast, brain age models
condense a complex multivariate pattern into a single
number (a deviation between true and predicted age). This
is often useful because it summarizes a complex pattern by
an interpretable score. On the other hand, it provides limited
ability to stratify individuals or identify which brain regions
underlie any observed deviation. This is important
because different subjects may have the same predicted
brain age because of distinct underlying abnormality pat-
terns [27].
Applications of normative modelling in
psychiatry
Normative modelling has been applied to many clinical
phenotypes: unsurprisingly, many applications have
focused on studying changes in brain organization across
the lifespan. More recently, studies have emerged applying
normative modelling to map the biological heterogeneity
underlying mental disorders (Table 1).2 Taken together, the
applications reviewed here show the flexibility of normative
modelling for many different clinical phenotypes, on the
basis of different clinical and biological measures. More-
over, they highlight the value of normative modelling for
studying individual differences in that they show that: (i) a
potentially small number of patients have alterations in the
same brain regions and (ii) that the pattern of individualized
regional differences detected by normative models can be
very different to case-control differences. For example,
normative deviations may be partially consistent with case
control-effects [17], very different [21] or evident in the
absence of case-control effects [24].
Normative modelling for big data
Normative modelling is useful for understanding variation in
‘big data’ cohorts. This parallels an increasing focus in
clinical neuroimaging towards acquiring large population-
based cohorts that capture a wide range of clinically relevant
variation [29–31]. The conventional motivation is to increase
statistical power for the detection of subtle effects [37]. While
this is undoubtedly important, such cohorts also provide an
excellent opportunity to understand structure in hetero-
geneous clinical populations. Normative modelling is ideal
for this due to its focus on understanding variation rather than
detecting mean effects and can be used to find distinct and
potentially non-overlapping patterns of abnormality.
On the other hand, big data cohorts introduce challenges,
including computational scaling of analytical methods to
many data points, requiring availability of modelled vari-
ables across all subjects and dealing with nuisance varia-
tion. For example, most large datasets include data from
multiple study sites, which increases the risk of missing data
and introduces the possibility that observed deviations
could be related to site variance. To address these concerns,
careful stratification procedures during model fitting and
cross-validation and explicitly modelling different sources
of variance are important (e.g. using hierarchical models).
Alternatively, for predictions on new sites, normative
models may be recalibrated on held-out normative control
data to ensure that the normative model remains appropriate
for the new data sample. There are many ways to achieve
this [38], but a simple approach involves adjusting the
mean, slope and variance after fitting a post hoc regression
to withheld subjects.
2 Note that we include some studies that can also be considered brain
age studies but that share salient features with normative models (e.g.,
ref. [14]), we refer the reader elsewhere for more detailed reviews of
brain age studies [27, 28].
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Another use for normative models is for calibrating
measures on different scales to a common normative
reference. In other words, separate normative models can be
estimated for different cognitive and biological mappings.
This has the effect of rescaling different variables to a
common reference range (for example, Z-statistics reflecting
the number of standard deviations each subject is from the
population norm). This forms an ideal set of features for the
application of clustering algorithms, in the spirit of preci-
sion medicine. Relative to application to the raw data, this
increases interpretability by scaling diverse data to popu-
lation norms and also can tease apart correlated symptom
domains more clearly than using clinical or biological
data alone.
Ultimately, estimating normative models to link multiple
phenotypic measurements with their multifaceted biological
underpinnings is likely to be very important to: (i) under-
stand disorders across multiple domains in the spirit of
RDoC and ROAMER; (ii) identify different groups of
patients with different atypical mechanisms; (iii) to better
understand healthy variation and how this relates to the
mechanisms of mental disorders and (iv) to move beyond
simple dimensional theories of mental disorders [25].
Study design considerations
The applications above show that normative modelling is
very flexible given the choice of covariates, response vari-
ables, target cohort and reference cohort. The choice of
reference cohort is particularly crucial; it is important that it
captures a wide range of variation in the reference popula-
tion. In paediatric medicine, the typical choice is a
population-based cohort containing thousands of partici-
pants. In psychiatry, it is also common to estimate norma-
tive models using population-based cohorts that include
participants across the full range of functioning (i.e. both
healthy and with disorders) [19, 20], although this is not the
only option and may not always be the optimal choice. For
neuroimaging, several large population-based cohorts are
being acquired [29, 31, 39], however these often focus on
specific lifespan periods [29] and are frequently enriched for
individuals ‘at-risk’ for mental disorders [31, 39]. More-
over, since these cohorts aim to address multiple questions,
they may lack rich clinical phenotyping measures that are
valuable for characterizing deviations (see below). Another
option is to apply normative models to existing cohorts (e.g.
based on case-control designs) [17, 23, 24]. In such cases,
either the whole cohort or only the healthy participants can
be used for the reference cohort. If the whole cohort is used,
it is important to remember that under a case-control para-
digm the frequency of the clinical phenotype is usually
much higher than the population prevalence (e.g. equal
numbers of cases and controls). If only the healthy subjects
are used as the reference, this can be considered an
approximation to a population-based cohort, which is rea-
sonable if the prevalence of the clinical phenotype in the
wider population is relatively low. In both cases, the
deviations should be interpreted with respect to the cohort
chosen. Regarding the choice of the target cohort, this can
be the same as the reference cohort, provided the predic-
tions are derived in an unbiased manner, for example, under
cross-validation.
Limitations
Normative modelling is a bottom-up approach to map var-
iation and should not be considered a substitute for
hypothesis testing or top-down theory driven approaches.
Rather, it is desirable to combine the benefits of both. For
example, combining top-down theory driven approaches
with supervised discriminative models [3] and normative
models. These can be used, respectively, to assess the
degree of group separation in a case-control sense and to
map the variation across individuals with respect to the
theory-driven model.
Another important consideration is that normative mod-
els do not directly indicate whether the deviations obtained
are clinically relevant. For example, deviations may be
biologically meaningful yet unrelated to psychopathology,
or they may be a result of artefactual variation (e.g. site
variation). Therefore, external validation of derived devia-
tions on external measures such as symptoms, genotype and
environmental factors is crucial, as are careful data pre-
processing and checking procedures.
Future developments: towards precision
psychiatry
Normative modelling provides a method to map deviations
from an expected pattern at the individual level. This has
been helpful to understand individual variation in the con-
text of brain development or ageing and also for mapping
variation across multiple cognitive domains and measures
of brain organization. This provides the potential to
understand individual variation across a multi-dimensional
cognitive space, consistent with initiatives such as RDoC
[6–8]. However, work remains to be done as to how these
can be integrated and to determine the clinical relevance of
individual variability. In other words, how, when and why
individual variability turns into vulnerability or resilience.
Indeed, a high priority is to develop methods that can
convert deviations from normative models to a stratification
of individuals. As noted, training clustering algorithms on
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the deviations from multiple normative models is one
option [12, 26]. However, conventional ‘hard’ clustering
algorithms allocate each subject to a single cluster and do
not accommodate the possibility of multiple overlapping
mechanisms operating in different individuals. Therefore, a
more promising route may be using ‘soft’ clustering algo-
rithms or other latent variable models that allow subjects to
be allocated to multiple potentially overlapping clusters or
risk profiles [40]. Another area of future work involves
explicitly modelling spatial information, which may
increase sensitivity for detection of spatially distributed
patterns of abnormality [41–43].
Conclusions and outlook
We have surveyed the emerging literature employing nor-
mative modelling to mental disorders. We have shown that
these methods are highly flexible: they can naturally
applied to estimating centiles of variation in brain growth
and to mappings between many aspects of behaviour,
cognition and biology. The most important feature of
normative models is their ability to make predictions at the
level of individual with respect to a normative pattern and
that they shift emphasis from studying mean effects to
understanding individual variation. They provide a means
by which modelling individual differences can be brought
from theory to concrete data analysis procedures and
therefore a promising route towards precision medicine in
psychiatry.
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